Infectious complications of solid organ transplantations.
暂无分享,去创建一个
[1] J. Cohen,et al. Epstein-Barr virus infection. , 2000, The New England journal of medicine.
[2] G. Mazariegos,et al. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. , 2000, Transplantation.
[3] Nina Singh,et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. , 2000, Transplantation.
[4] B. Alexander,et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. , 2000, Transplantation.
[5] V. Calvez,et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. , 2000, Transplantation.
[6] H. Einsele,et al. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. , 2000, The Journal of infectious diseases.
[7] Y. Chang,et al. Kaposi's sarcoma. , 2000, The New England journal of medicine.
[8] A. Humar,et al. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. , 2000, The Journal of infectious diseases.
[9] P. Griffiths,et al. Betaherpesviruses in transplant recipients. , 2000, The Journal of antimicrobial chemotherapy.
[10] F. Baldanti,et al. High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders , 2000, Journal of Clinical Microbiology.
[11] I. Sia,et al. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. , 2000, Clinical microbiology reviews.
[12] E. Kieff,et al. Epstein-barr virus-induced posttransplant lymphoproliferative disorders , 1999 .
[13] R. Busuttil,et al. Prophylactic Fluconazole in Liver Transplant Recipients , 1999, Annals of Internal Medicine.
[14] E. Trulock,et al. The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation. , 1999, Transplantation.
[15] G. Verhoef,et al. Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.
[16] Nina Singh,et al. Invasive aspergillosis in transplant recipients. , 1999, Medicine.
[17] A. Arroliga,et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] S. Knechtle,et al. Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. , 1998, Transplantation.
[19] W. Irish,et al. Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] S. Zielen,et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. , 1998, Transplantation.
[21] M. Wernli,et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. , 1998, The New England journal of medicine.
[22] Nina Singh,et al. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] K. Byth,et al. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. , 1998, Transplantation.
[24] F. Baldanti,et al. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. , 1998, Transplantation.
[25] J. Aster,et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. , 1998, The New England journal of medicine.
[26] P. Muñoz,et al. Pneumonia After Heart Transplantation: A Multiinstitutional Study , 1998 .
[27] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.
[28] D. Snydman,et al. Infective Endocarditis in Solid Organ Transplant Recipients , 1998 .
[29] R. Avery. Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients. , 1998, Current opinion in cardiology.
[30] E. Bouza,et al. Rhodococcus equi infection in transplant recipients: case report and review of the literature. , 1998, Transplantation.
[31] S. Strom,et al. Current status of intestinal transplantation in children. , 1998, Journal of pediatric surgery.
[32] M. Gettman,et al. Urological complications after kidney-pancreas transplantation. , 1998, The Journal of urology.
[33] Nina Singh,et al. Invasive aspergillosis in liver transplant recipients in the 1990s. , 1997, Transplantation.
[34] Nina Singh,et al. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. , 1997, Transplantation.
[35] C. Chaparro,et al. Infections in lung transplant recipients. , 1997, Clinics in chest medicine.
[36] C. Cantarell,et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. , 1997, Transplantation.
[37] T. Starzl,et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. , 1997, Archives of surgery.
[38] D. Snydman,et al. Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients , 1997, Annals of Internal Medicine.
[39] I. Marino,et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] C. Payá,et al. Infections in solid-organ transplant recipients , 1997, Clinical microbiology reviews.
[41] R. Wiesner,et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. , 1996, Transplantation.
[42] S. Todo,et al. Infectious complications after small bowel transplantation in adults: an update. , 1996, Transplantation proceedings.
[43] J. Perfect,et al. Fungal Infections in Lung and Heart‐Lung Transplant Recipients: Report of 9 Cases and Review of the Literature , 1996, Medicine.
[44] J. Fung,et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] C. Yancy,et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[46] J. Maurer,et al. Aspergillus infection in single and double lung transplant recipients. , 1996, Transplantation.
[47] N. Warren,et al. Actinomycosis, nocardiosis, and actinomycetoma. , 1996, Dermatologic clinics.
[48] R. Busuttil,et al. Infections in liver transplant recipients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] N. Cary,et al. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[50] N. Rolando,et al. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients , 1995, Hepatology.
[51] J. Velosa,et al. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] V. Yu,et al. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] E. Lennette,et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. , 1995, Transplantation.
[54] D. Glotz,et al. Invasive aspergillosis after transplantation. , 1995, Transplantation proceedings.
[55] O. Ringdén,et al. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. , 1995, Transplantation.
[56] T. Habermann,et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[57] M. Samore,et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. , 1994, The Journal of infectious diseases.
[58] N. Kneteman,et al. Comparative Risk of Bloodstream Infection in Organ Transplant Recipients , 1994, Infection Control & Hospital Epidemiology.
[59] C. Payá,et al. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] R. Rubin,et al. Clinical aspects of fungal infection in organ transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[61] F. Detterbeck,et al. Infectious complications of lung transplantation. Impact of cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.
[62] L. Miller,et al. Infection after heart transplantation: a multiinstitutional study , 1994 .
[63] W. Petri,et al. Infections in heart transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] V. Yu,et al. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] J. Cooper,et al. The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. , 1993, The Journal of thoracic and cardiovascular surgery.
[66] M. Kramer,et al. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. , 1993, Archives of internal medicine.
[67] J. Loyd,et al. Infection in the transplanted and native lung after single lung transplantation. , 1993, Chest.
[68] A. Mehta,et al. Lung transplantation: the Cleveland Clinic experience. , 1993, Cleveland Clinic journal of medicine.
[69] R. Rubin. Infectious disease complications of renal transplantation. , 1993, Kidney international.
[70] J. Thompson,et al. Disseminated Strongyloides stercoralis infection. , 1993, Southern medical journal (Birmingham, Ala. Print).
[71] A. Tzakis,et al. Selective decontamination in pediatric liver transplants. A randomized prospective study. , 1993, Transplantation.
[72] C. Payá,et al. Fungal infections in solid-organ transplantation. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] J. Copeland,et al. Coccidioidomycosis and heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] T. F. Smith,et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. , 1993, Journal of hepatology.
[75] J. Serody,et al. Blastomycosis in transplant recipients: report of a case and review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] T. Starzl,et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. , 1992, The Journal of infectious diseases.
[77] V. Yu,et al. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. , 1992, American journal of infection control.
[78] R. De Maria,et al. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[79] J. Emond,et al. Patterns of infection after pediatric liver transplantation. , 1992, American journal of diseases of children.
[80] B. Radovancević,et al. Bacterial mediastinitis after heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[81] P. D. del Nido,et al. Toxoplasmosis in pediatric recipients of heart transplants. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] G. Patterson,et al. Infectious complications following isolated lung transplantation. , 1992, Chest.
[83] G. Klintmalm,et al. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. , 1992, Transplantation proceedings.
[84] J. Emond,et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. , 1991, Reviews of infectious diseases.
[85] J. Cofer,et al. Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. , 1991, Transplantation proceedings.
[86] R. Fisher,et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.
[87] J. Dummer,et al. Infectious complications in pulmonary allograft recipients. , 1990, Clinics in chest medicine.
[88] E. Gilbert,et al. Increased risk of pneumococcal infections in cardiac transplant recipients. , 1990, Transplantation.
[89] K. Gottesdiener. Transplanted infections: donor-to-host transmission with the allograft. , 1989, Annals of internal medicine.
[90] T. F. Smith,et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. , 1989, Mayo Clinic proceedings.
[91] S. Chapman,et al. Nocardial Infections in Renal Transplant Recipients , 1989, Medicine.
[92] T. Starzl,et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. , 1988, The Journal of infectious diseases.
[93] P E Oyer,et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. , 1987, Annals of internal medicine.
[94] W. Schaffner,et al. Opportunistic strongyloidiasis in renal transplant recipients. , 1986, Transplantation.
[95] T. Peters,et al. TRANSMISSION OF TUBERCULOSIS BY KIDNEY TRANSPLANTATION , 1984, Transplantation.
[96] Y. Naot,et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. , 1983, Annals of internal medicine.
[97] J. Galgiani,et al. Coccidioidomycosis in renal replacement therapy. , 1982, Archives of internal medicine.
[98] R. Rubin,et al. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. , 1982, Reviews of infectious diseases.
[99] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .